Other
Julie Pendergast
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
N/A
3(100.0%)
3Total
N/A(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT05858008Not ApplicableRecruiting
Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment
Role: lead
NCT04893226Not ApplicableRecruiting
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
Role: lead
NCT04097886Not ApplicableCompleted
Timed Exercise Study
Role: lead
All 3 trials loaded